相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy
Paula S. Ginter et al.
MODERN PATHOLOGY (2021)
The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients
C. van Dooijeweert et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Significant inter- and intra-laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands
Carmen van Dooijeweert et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor Positive Early Breast Cancer
Shin Hye Yoo et al.
CLINICAL BREAST CANCER (2020)
Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004-2015
Lu Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Variation in breast cancer grading: the effect of creating awareness through laboratory-specific and pathologist-specific feedback reports in 16 734 patients with breast cancer
Carmen van Dooijeweert et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
The effect of an e-learning module on grading variation of (pre)malignant breast lesions
Carmen van Dooijeweert et al.
MODERN PATHOLOGY (2020)
Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer
Julia E. C. van Steenhoven et al.
HISTOPATHOLOGY (2020)
Prognostic models for breast cancer: a systematic review
Minh Tung Phung et al.
BMC CANCER (2019)
Breast Cancer, Version 3.2018 Featured Updates to the NCCN Guidelines
Matthew P. Goetz et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Predicting breast tumor proliferation from whole-slide images: The TUPAC16 challenge
Mitko Veta et al.
MEDICAL IMAGE ANALYSIS (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Progesterone receptor status and tumor grade predict the 21-gene recurrence score of invasive lobular breast cancer
San-Gang Wu et al.
BIOMARKERS IN MEDICINE (2019)
Uptake of the 21-Gene Assay Among Women With Node-Positive, Hormone Receptor-Positive Breast Cancer
Megan C. Roberts et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data
Amila Orucevic et al.
BREAST (2019)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx
Fabrice Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline
N. Lynn Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
H. J. Burstein et al.
ANNALS OF ONCOLOGY (2019)
Interobserver variability in breast carcinoma grading results in prognostic stage differences
Kimmie Rabe et al.
HUMAN PATHOLOGY (2019)
A nationwide registry-based cohort study of the MammaPrint genomic risk classifier in invasive breast cancer
Floris H. Groenendijk et al.
BREAST (2018)
Tumor grade and progesterone receptor status predict 21-gene recurrence score in early stage invasive breast carcinoma
Jing Li Huang et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
David J. Press et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Interlaboratory variability of Ki67 staining in breast cancer
Cornelia M. Focke et al.
EUROPEAN JOURNAL OF CANCER (2017)
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
Babak Ehteshami Bejnordi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study
Brigette A. Davis et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Ki67 assessment in breast cancer: an update
Frederique Penault-Llorca et al.
PATHOLOGY (2017)
Low utility of Oncotype DX® in the clinic
Luisel J. Ricks-Santi et al.
CANCER MEDICINE (2017)
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G. Curigliano et al.
ANNALS OF ONCOLOGY (2017)
St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods
Cornelia M. Focke et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
Amila Orucevic et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Short-term breast cancer survival in relation to ethnicity, stage, grade and receptor status: national cohort study in England
Henrik Moller et al.
BRITISH JOURNAL OF CANCER (2016)
Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer
Rekha Gyanchandani et al.
CLINICAL CANCER RESEARCH (2016)
Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours
Cornelia M. Focke et al.
HISTOPATHOLOGY (2016)
21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile
Jagar Jasem et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mitosis Counting in Breast Cancer: Object-Level Interobserver Agreement and Comparison to an Automatic Method
Mitko Veta et al.
PLOS ONE (2016)
Breast Cancer Biology and Ethnic Disparities in Breast Cancer Mortality in New Zealand: A Cohort Study
Sanjeewa Seneviratne et al.
PLOS ONE (2015)
Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based study
Jinzhong Sun et al.
ONCOLOGY LETTERS (2015)
Discrepancy between routine and expert pathologists' assessment of non-palpable breast cancer and its impact on locoregional and systemic treatment
Emily L. Postma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study
M. Puig-Vives et al.
GYNECOLOGIC ONCOLOGY (2013)
Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing?
K. H. Allison et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Barriers to the Use of Personalized Medicine in Breast Cancer
Christine B. Weldon et al.
JOURNAL OF ONCOLOGY PRACTICE (2012)
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
Jack Cuzick et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment
J. M. Bueno-de-Mesquita et al.
ANNALS OF ONCOLOGY (2010)
ONCOPOOL - A European database for 16,944 cases of breast cancer
R. W. Blamey et al.
EUROPEAN JOURNAL OF CANCER (2010)
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
Britta Weigelt et al.
JOURNAL OF PATHOLOGY (2010)
Breast cancer prognostic classification in the molecular era: the role of histological grade
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2010)
Loss of 16q in High Grade Breast Cancer is Associated with Estrogen Receptor Status: Evidence for Progression in Tumors with a Luminal Phenotype?
Rachael Natrajan et al.
GENES CHROMOSOMES & CANCER (2009)
Histological grading of invasive breast carcinoma - a simplification of existing methods in a large conservation series with long-term follow-up
Jeremy St J. Thomas et al.
HISTOPATHOLOGY (2009)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic significance of Nottingham histologic grade in invasive breast carcinoma
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
Matthew J. Ellis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Predicting features of breast cancer with gene expression patterns
Xuesong Lu et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati et al.
BREAST CANCER RESEARCH (2008)
Gene expression profiling: Does it add predictive accuracy to clinical characteristics in cancer prognosis?
Daniela Dunkler et al.
EUROPEAN JOURNAL OF CANCER (2007)
Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study
TA Longacre et al.
MODERN PATHOLOGY (2006)
Impact of a national external quality assessment scheme for breast pathology in the UK
IO Ellis et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Role of mammography screening as a predictor of survival in postmenopausal breast cancer patients
J Anttinen et al.
BRITISH JOURNAL OF CANCER (2006)
Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years
JPA Baak et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Role of detection method in predicting breast cancer survival: Analysis of randomized screening trials
Y Shen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index:: reproducibility of grade and advantages of proliferation index
JS Meyer et al.
MODERN PATHOLOGY (2005)
Time-dependent effects on survival in breast carcinoma -: Results of 20 years of follow-up from the Swedish two-county study
J Warwick et al.
CANCER (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Good Old clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers
P Edén et al.
EUROPEAN JOURNAL OF CANCER (2004)
Quantitative association between, HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
G Konecny et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Long term prognostic value of Nottingham histological grade and its components in early (pT1 N0M0) breast carcinoma
S Frkovic-Grazio et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Prognostic factors in node-negative breast cancer - A review of studies with sample size more than 200 and follow-up more than 5 years
AN Mirza et al.
ANNALS OF SURGERY (2002)
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry - An Eastern Cooperative Oncology Group study (2192)
DL Page et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2001)
Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: Results from a nationwide study
J Lundin et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Pathology characteristics that optimize outcome prediction of a breast screening trial
T. J. Anderson et al.
BRITISH JOURNAL OF CANCER (2000)
Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: Results from the Eastern Cooperative Oncology Group companion study, EST 4189
JF Simpson et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
